comparison of the effect of Adalimumab and Infleximab in patients with Ankylosing Spondilitis presenting to Alzahra hospital
Phase 3
Recruiting
- Conditions
- Ankylosing Spondylitis.Ankylosing spondylitis
- Registration Number
- IRCT20200412047047N1
- Lead Sponsor
- Esfahan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 80
Inclusion Criteria
Patients with known AS according to the American College of Rheumatology
not responded to at least 3 months of treatment with 2 different NSAIDs
candidates for initiating biological drugs.
Exclusion Criteria
having contraindications to receiving anti-TNF drugs including active infection or being at high risk for infection
past medical history of cancer
past medical history of systemic lupus erythmatosis,
past medical history of multiple sclerosis
past medical history of an autoimmune disease.
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method